Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar:29:101604.
doi: 10.1016/j.pdpdt.2019.101604. Epub 2019 Nov 17.

Choriocapillary vascular density in central serous chorioretinopathy complicated by choroidal neovascularization

Affiliations

Choriocapillary vascular density in central serous chorioretinopathy complicated by choroidal neovascularization

Gilda Cennamo et al. Photodiagnosis Photodyn Ther. 2020 Mar.

Abstract

Background: To evaluate choriocapillary vascular density (CVD) in eyes with central serous chorioretinopathy (CSC) complicated by choroidal neovascularization (CNV), at baseline and after intravitreal injections (IVR) of Ranibizumab, using optical coherence tomography angiography (OCTA).

Methods: Twelve eyes of 12 patients were enrolled as group 1 and 12 unaffected fellow eyes formed group 2. Twelve eyes of 12 healthy controls were the control group.

Results: CVD in Group 1 did not differ before and after treatment. CVD of Group 1 was significantly lower compared with controls at baseline (whole, parafovea and fovea p < 0.05). CVD of controls resulted significantly higher than Group 2 at baseline (whole, parafovea and fovea p < 0.05). There were not significant differences in CVD between Groups 1 and 2 at baseline (p > 0.05).

Conclusions: OCTA revealed a choriocapillary hypoperfusion that may be responsable for the beginning of this disease and the late development of CNV.

Keywords: Central serous chorioretinopathy; Choriocapillary vascular density; Choroidal neovascularization; OCTA.

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest None.

MeSH terms

Substances

LinkOut - more resources